Filed before 2025Filed 16 May 2022
RxAnte, Inc. has sold $10.9M so far
RxAnte, Inc., a health care company based in Portland, ME, has sold $10.9M so far in its debt round, according to a filing dated 16 May 2022.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 16 May 2022
- First filed
- 22 October 2020
- Round
- Debt round (amended filing)
- Amount sold
- $10.9M
- Offering size
- $10.9M
- Investors so far
- 7
- Based in
- Portland, ME
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 55% of the 1,764 tracked raises with an amount filed in 2022, and than 57% of the 123 in health care.
RxAnte, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 16 May 2022 | Amended filing | $10.9M | This raise |
| 22 Oct 2020 | New filing | $5.5M | This raise |
More with FT Openova on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.